Relationship of preoperative PSA velocity to histopathological findings in the surgical specimen and survival after radical prostatectomy

Horninger, 2002, Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostatespecific antigen levels of 2 to 4 nanograms per milliliter, Urology, 60, 31, 10.1016/S0090-4295(02)01693-X Stamey, 2004, The prostate specific antigen era in the United Status is over for prostate cancer: what happened in the last 20 years?, J Urol, 172, 1297, 10.1097/01.ju.0000139993.51181.5d Carter, 1992, Longitudinal evaluation of prostate-specific antigen levels in men with without prostate disease., JAMA, 267, 2215, 10.1001/jama.267.16.2215 Eggener, 2006, Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy, J Urol, 176, 1399, 10.1016/j.juro.2006.06.045 D’Amico, 2004, Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy, N Eng J Med, 351, 125, 10.1056/NEJMoa032975 Yu, 2006, Comparison of methods for calculating prostate specific antigen velocity, J Urol, 176, 2427, 10.1016/j.juro.2006.08.006 1997, 170 D’Amico, 1998, Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for localized prostate cancer, JAMA, 280, 969, 10.1001/jama.280.11.969 Loeb, 2008, Does prostate growth confound prostate specific antigen velocity? Data from the Baltimore longitudinal study of aging, J Urol, 180, 1314, 10.1016/j.juro.2008.06.033 Rodríguez-Alonso, 2008, Importancia de la velocidad y la densidad de PSA en la predicción de cáncer de próstata en la pieza de RTU o adenomectomía de pacientes con biopsia prostática previa negativa, Actas Urol Esp, 32, 779, 10.4321/S0210-48062008000800003 Partin, 1994, Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrente from distant metastases, Urology, 43, 649, 10.1016/0090-4295(94)90180-5 Sengupta, 2008, Prostate specific antigen kinetics in the management of prostate cancer, J Urol, 179, 821, 10.1016/j.juro.2007.10.023 Loeb, 2008, Prostate specific antigen assay standardization bias could affect clinical decision making, J Urol, 180, 1959, 10.1016/j.juro.2008.07.036 Sölétormos, 2005, Biological variation of total prostate-specific antigen: a survey of Publisher estimates and consequences for clinical practice, Clin Chem, 51, 1342, 10.1373/clinchem.2004.046086 Connolly, 2007, Methods of calculating prostate-specific antigen velocity, Eur Urol, 52, 1044, 10.1016/j.eururo.2006.12.017 King, 2007, Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: A report from SEARCH, Urology, 69, 732, 10.1016/j.urology.2007.01.019 Sengupta, 2005, Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy, J Urol, 174, 2191, 10.1097/01.ju.0000181209.37013.99 Patel, 2005, Preoperative PSA velocity is an independent prognostic factor for relapse alter radical prostatectomy, J Clin Oncol, 23, 6157, 10.1200/JCO.2005.01.2336 Berger, 2007, Large-scale study of clinical impact of PSA velocity: longterm PSA kinetics as method of differentiating men with from those without prostate cancer, Urology, 69, 134, 10.1016/j.urology.2006.09.018 Thiel, 1997, Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localizad prostate cancer, Urology, 49, 716, 10.1016/S0090-4295(97)00068-X Freeland, 2001, Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy, Urology, 57, 476, 10.1016/S0090-4295(00)01016-5 Stephenson, 2006, Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition, J Clin Oncol, 24, 3973, 10.1200/JCO.2005.04.0756 Pound, 1999, Natural history of progression after PSA elevation following radical prostatectomy, JAMA, 281, 1591, 10.1001/jama.281.17.1591 Berger, 2006, Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: results from a screening population, Urology, 68, 1067, 10.1016/j.urology.2006.06.020 Hull, 2002, Cancer control with radical prostatectomy alone in 1000 consecutive patients, J Urol, 167, 528, 10.1016/S0022-5347(01)69079-7 Yu, 2007, The association between total specific antigen concentration and prostate specific antigen velocity, J Urol, 177, 1298, 10.1016/j.juro.2006.12.003